-
Chondrial Therapeutics Merges With Zafgen, Starts Operating as Larimar Therapeutics
Chondrial has merged with Zafgen and will start operating as Larimar Therapeutics, which will now be responsible for the clinical development of CTI-1601. Read more about the merger here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.